Charles Schwab Investment Management Inc Allovir, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Allovir, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 57,055 shares of ALVR stock, worth $26,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,055

Previous 344,562 83.44%

Holding current value

$26,815

Previous $248,000 81.45%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.7 - $0.82 $201,254 - $235,755	-287,507 Reduced 83.44%	57,055 $46,000
Q2 2024 Aug 12, 2024	SELL	$0.72 - $0.82 $83,710 - $95,336	-116,264 Reduced 25.23%	344,562 $248,000
Q1 2024 May 08, 2024	SELL	$0.64 - $0.78 $9,603 - $11,704	-15,006 Reduced 3.15%	460,826 $350,000
Q4 2023 Feb 06, 2024	BUY	$0.68 - $2.39 $42,876 - $150,696	63,053 Added 15.28%	475,832 $323,000
Q3 2023 Nov 08, 2023	BUY	$2.15 - $3.64 $176,087 - $298,119	81,901 Added 24.75%	412,779 $887,000
Q2 2023 Aug 09, 2023	BUY	$3.17 - $5.82 $84,610 - $155,341	26,691 Added 8.77%	330,878 $1.12 Million
Q1 2023 May 11, 2023	BUY	$3.94 - $7.05 $2,828 - $5,061	718 Added 0.24%	304,187 $1.2 Million
Q4 2022 Feb 13, 2023	BUY	$4.7 - $9.98 $20,722 - $44,001	4,409 Added 1.47%	303,469 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $334,224 - $711,339	80,926 Added 37.1%	299,060 $2.36 Million
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $42,412 - $91,850	13,010 Added 6.34%	218,134 $851,000
Q1 2022 May 13, 2022	SELL	$6.75 - $13.52 $22,362 - $44,791	-3,313 Reduced 1.59%	205,124 $1.39 Million
Q4 2021 Feb 11, 2022	BUY	$12.94 - $25.99 $55,512 - $111,497	4,290 Added 2.1%	208,437 $2.7 Million
Q3 2021 Nov 16, 2021	BUY	$16.97 - $25.06 $1.05 Million - $1.55 Million	61,931 Added 43.55%	204,147 $5.12 Million
Q2 2021 Aug 16, 2021	SELL	$19.44 - $25.06 $13,957 - $17,993	-718 Reduced 0.5%	142,216 $2.81 Million
Q1 2021 May 17, 2021	BUY	$20.81 - $45.5 $615,434 - $1.35 Million	29,574 Added 26.09%	142,934 $3.35 Million
Q4 2020 Feb 16, 2021	BUY	$23.94 - $46.81 $93,749 - $183,307	3,916 Added 3.58%	113,360 $4.36 Million
Q3 2020 Nov 13, 2020	BUY	$21.05 - $42.7 $2.3 Million - $4.67 Million	109,444 New	109,444 $3.01 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $43.7M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Allovir, Inc. Transaction History